Urosepsis;UROSEPSIS

Tidsskrift for den Norske Laegeforening

Volumn 117, Issue 7, 1997, Pages 959-962

  Moen, Harald ^a   Von Der Lippe, Elisabeth ^b   Tveter, Kjell J ^c  

^a Intensivavdelingen   (Norway)

^b Infeksjonsmedisinsk Avdeling   (Norway)

^c Urologisk Avdeling   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPHOTERICIN B; AMPICILLIN; ANTIBIOTIC AGENT; CEFTAZIDIME; DOBUTAMINE; FLUCONAZOLE; NORADRENALIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

HUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; SEPTICEMIA; SHORT SURVEY; SYMPTOMATOLOGY; URINARY TRACT INFECTION;

HUMANS; SEPSIS; URINARY TRACT INFECTIONS;

EID: 0031040096     PISSN: 00292001     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (13)

1. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 1995; 101: 1644-55.
2. Morris DL, Chambers HF, Morris MG, Tande MA. Hemodynamic characteristics of patients with hypothermia due to occult infection and other causes. Ann Intern Med 1985; 102: 483-90.
3. Calandra T, Comette A. Antibiotic treatment for gramnegative bacteria. Infect Dis Clin North Am 1991; 5: 817-34.
4. Natanson C, Hoffman WD, Parillo JE. Septic shock: the cardiovascular abnormality and therapy. J Cardiothorac Anesth 1989; 3: 214-27.
5. Lee RM, Balk RA, Bone RC. Ventilatory support in the management of septic patients. Crit Care Clin 1989; 5: 157-75.
6. Parillo JE. Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction and therapy. Ann Intern Med 1990; 113: 227-42.
7. Calandra T, Baumgartner JF, Grau GE, Wu MM, Lambert PH, Schelleken J et al. Prognostic values of tumor necrosis factor/cachectin, interleukin-/interferon-alpha and interferon-gamma in the serum of patients in septic shock. J Infect Dis 1990; 161: 982-7.
8. Sobel JD. Host defenses. Infect Dis Clin North Am 1987; 1: 751-72.
9. Stamm WE, Hooton TM, Johnson JR, Johnson C, Stapleton A, Roberts PL et al. Urinary tract infections: from pathogenesis to treatment. J Infect Dis 1989; 159: 400-6.
10. Parker MM, Shelhamer JH, Natanson C, Alling DW, Parillo JE. Serial cardio vascular variables in survivors and non survivors of human septic shock. Crit Care Med 1987; 15: 923-9.
11. Parillo JE. Pathogenetic mechanisms of septic shock. N Engl J Med 1993; 328: 1471-7.
12. Harris RI, Musher DM, Bloom K, Gathe J, Rice L, Sugarman B et al. Manifestations of sepsis. Arch Intern Med 1987; 147: 1895-1906.
13. Fein AM, Lippmann M, Holzman H, Eliraz A, Golberg SK. The risk factors, incidence and prognosis of ARDS following septicemia. Chest 1983; 83: 40-2.